| 发明名称 | Salt of abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them | ||
| 摘要 | Abexinostat tosylate of formula (II):; and its crystalline form I characterized by its X-Ray powder diffraction diagram, its Raman spectrum and its solid-state 13C CP/MAS NMR spectrum. ;Medicinal products containing the same which are useful in the treatment of cancer. | ||
| 申请公布号 | US9115108(B2) | 申请公布日期 | 2015.08.25 |
| 申请号 | US201414195186 | 申请日期 | 2014.03.03 |
| 申请人 | PHARMACYCLICS, INC. | 发明人 | Pimont-Garro Anne;Letellier Philippe |
| 分类号 | C07D307/85;C07C309/30 | 主分类号 | C07D307/85 |
| 代理机构 | Hueschen and Sage | 代理人 | Hueschen and Sage |
| 主权项 | 1. A crystalline form I of abexinostat tosylate of formula (II):having an X-ray powder diffraction diagram having the following diffraction lines (Bragg's angle 2 theta, expressed in degrees ±0.2°): 6.50, 9.94, 11.35, 12.33, 14.08, 18.95, 21.08, and 27.05. | ||
| 地址 | Sunnyvale CA US | ||